 |
|
Fatigue and Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Multiple Sclerosis
Michaela Gottschalk, MD;
Tania Kümpfel, MD;
Peter Flachenecker, MD;
Manfred Uhr, MD;
Claudia Trenkwalder, MD;
Florian Holsboer, MD;
Frank Weber, MD
Arch Neurol. 2005;62:277-280.
Background Fatigue is a common and disabling symptom in patients with multiple sclerosis (MS). Underlying mechanisms postulated so far have involved localization of brain lesions and abnormalities of the neuroendocrine system and cytokine regulation.
Objective To investigate the relationship between fatigue and the hypothalamo-pituitary-adrenal (HPA) axis in patients with MS.
Design A prospective survey.
Setting Outpatient and inpatient study at the Max Planck Institute of Psychiatry, Munich, Germany.
Patients Thirty-one patients with clinically definite MS, a relapsing-remitting disease course, and without MS-specific treatment.
Interventions Assessment of fatigue with 3 questionnaires: the Fatigue Severity Scale (FSS), the Modified Fatigue Impact Scale (MFIS), and the Visual Analog Scale. Assessment of HPA axis regulation with the combined dexamethasone–corticotropin releasing hormone (Dex-CRH) test.
Results The FSS score was significantly correlated with the MFIS score. Patients with fatigue had significantly elevated adrenocorticotropin (ACTH) levels in the combined Dex-CRH test.
Conclusions In contrast to results for chronic fatigue syndrome, where a hyporeactivity of the HPA axis has been shown, MS patients with fatigue exhibited a higher activity of the HPA axis than those without fatigue, as evidenced by significantly increased ACTH concentrations. Proinflammatory cytokines, known to be elevated in patients with MS, may cause both HPA axis alterations and fatigue.
Author Affiliations: Max Planck Institute of Psychiatry (Drs Gottschalk, Uhr, Holsboer, and Weber) and Institute of Neuroimmunology, Ludwig-Maximilians-University (Dr Kümpfel), Munich, Germany; Hospital Bavaria, Bad Kissingen, Germany (Dr Flachenecker); and Paracelsus-Elena Hospital, Kassel, Germany (Dr Trenkwalder).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Origin of Fatigue in Multiple Sclerosis: Review of the Literature
Kos et al.
Neurorehabil Neural Repair 2008;22:91-100.
ABSTRACT
Editorial
Krupp
Mult Scler 2006;12:367-368.
Sleep and fatigue in multiple sclerosis
Stanton et al.
Mult Scler 2006;12:481-486.
ABSTRACT
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone
Tellez et al.
Mult Scler 2006;12:487-494.
ABSTRACT
Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?
Heesen et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:34-39.
ABSTRACT
| FULL TEXT
|
